Pre Market 9-28-2016

By September 28, 2016Pro Webinars

Crazy insane day, I almost could not process it all, great watch if you want to see the potential in day trading low priced stocks!

Trading Notes

9/28/2016 6:28 AM – BOULDER, Colo., Sept. 27, 2016 /PRNewswire/ — Array BioPharma Inc. (Nasdaq: ARRY) announced today the pricing of an underwritten public offering of 18,400,000 shares of its common stock at a public offering price of $6.25 per share.
9/28/2016 6:42 AM Sympathy checker – coming soon to STT – but for now Google finance
9/28/2016 6:45 AM $ARRY nice base at $6.30 in pre market, decent volume
9/28/2016 6:51 AM $RGSE $5.20
9/28/2016 7:25 AM $AVXL hated by all short sellers – AdamF bash
9/28/2016 7:26 AM $SEED good news, no edge to “value it”
9/28/2016 7:44 AM $TWLO 70+ nice swing!!
9/28/2016 7:57 AM Good call in Pro Q and A by member about offering being “priced in” on $ARRY
9/28/2016 8:21 AM – $GALT Downgrading to Sell; PT to $0.75–Roth Capital
9/28/2016 8:30 AM Welsh is a jerk, but good follow: $SEED over $40 mil in debt, sold their main asset with to strength balance sheet. Not a chaseable event in my opinion.
9/28/2016 9:27 AM $OPTT Look for push through $8.00
9/28/2016 9:29 AM $GBSN only with volume and only over $3 otherwise ignore
9/28/2016 9:29 AM $KTOV over $4.00
9/28/2016 9:32 AM Out $RGSE flat, stuck to plan.
9/28/2016 9:38 AM $DNR
9/28/2016 9:40 AM I would take any $AVXL off here at 4.40-4.30’s
9/28/2016 9:41 AM $GALT to reason to be paient when you are up 40%+ in a couple days.
9/28/2016 9:43 AM $GBSN $OPTT, $RGSE $ARRY $AVXL gotta stop there for main watches.

How much has this post helped you?
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Leave a Reply